Local ablation for hepatocellular carcinoma in Taiwan: Different points between Japan, Asia and West

Oncology

Volumn 78, Issue SUPPL. 1, 2010, Pages 102-106

  Lin, Shi Ming ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Artificial ascites; Artificial pleural effusion; Hepatocellular carcinoma; High risk location; Interactive algorithm; Local ablation; Local tumor progression; Radiofrequency ablation; Survival

Indexed keywords

ACETIC ACID; ALCOHOL;

ALGORITHM; CANCER GROWTH; CANCER SURVIVAL; COMPARATIVE STUDY; ELECTRODE; HUMAN; JAPAN; LIVER CELL CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; TAIWAN;

ASIA; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; ETHANOL; HUMANS; JAPAN; LIVER NEOPLASMS; TAIWAN; TREATMENT OUTCOME;

EID: 77954473718     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000315237     Document Type: Review

References (34)

1. Bosch FX, Ribes J, Diaz M, Cleries R: Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127:S5-S16.
2. Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, Kawasaki S: Surgery for small liver cancers. Semin Surg Oncol 1993; 9: 298-304.
3. Lee CS, Sheu JC, Wang M, Hsu HC: Longterm outcome after surgery for asymptomatic small hepatocellular carcinoma. Br J Surg 1996; 83: 330-333.
4. Chen MF, Hwang TL, Jeng LB, Jan YY, Wang CS, Chou FF: Hepatic resection in 120 patients with hepatocellular carcinoma. Arch Surg 1989; 124: 1025-1028.
5. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodes J: Clinical management of hepatocellular carcinoma: conclusions of the Barcelona 2000 EASL Conference. J Hepatol 2001; 35: 421-430.
6. Bruix J, Sherman M: AASLD practice guideline: management of hepatocellular carcinoma. Hepatolgy 2005; 42: 1208-1236.
7. Lin SM: Recent advances in radiofrequency ablation in the treatment of hepatocellular carcinoma and metastatic liver cancers. Chang Gung Med J 2009; 32: 22-31.
8. Lin SM, Lin DY: Percutaneous local ablation therapy in small hepatocellular carcinoma. Chang Gung Med J 2003; 26: 308-314.
9. Arii S, Yamaoka Y, Futagawa S, Inoue K, Kobayashi K, Kojiro M, Makuuchi M, Nakamura Y, Okita K, Yamada R: Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinoma: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 2000; 32: 1224-1229.
10. Huang GT, Lee PH, Tsang YM, Lain MY, Yang PM, Hu RH, Chen PJ, Kao JH, Sheu JC, Lee CJ, Chen DS: Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study. Ann Surg 2005; 242: 36-42.
11. Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, Zhang YQ, Lin XJ, Lau WY: A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006; 243: 321-328.
12. Lin SM, Chu CM: Percutaneous tumor ablation or surgical resection for small hepatocellular carcinoma? J Gastroenterol Hepatol 2007; 22: 1561-1564.
13. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC: Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma ≤ 4 cm. Gastroenterology 2004; 127: 1714-1723.
14. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC: Randomized controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005; 54: 1151-1156.
15. Shiina S, Teratani T, Obi S, Sato S, Tateishi R, Fujishoma T, Ishikawa T, Koike Y, Yoshida H, Kawabe T, Omata M: A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005; 129: 122-130.
16. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS: Small hepatocellular carcinoma: treatment with radiofrequency ablation versus ethanol injection. Radiology 1999; 210: 655-661.
17. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Ierace T, Solbiati L, Gazelle GS: Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions. Radiology 2000; 214: 761-768.
18. Lin SM, Lin CJ, Chung HJ, Hsu CW, Peng CY: Power rolloff during interactive radiofrequency ablation can enhance necrosis when treating hepatocellular carcinoma. Am J Roentgenol 2003; 180: 151-157.
19. Lin SM, Lin CC, Chen WT, Chen YC, Hsu CW: Radiofrequency ablation for hepatocellular carcinoma: a prospective comparison of four radiofrequency devices. J Vasc Interv Radiol 2007; 18: 1118-1125.
20. Lencioni RA, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L, Frings H, Laubenberger J, Zuber I, Blum HE, Bartolozzi C: Small hepatocellular carcinoma in cirrhosis: randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228: 235-240.
21. Bouza C, Lopez-Cuadrado T, Alcazar R, Saz- Parkinson Z, Amate ZM: Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma. BMC Gastroenterol 2009; 9: 31.
22. Teratani T, Yoshida H, Shiina S, Obi S, Sato S, Tateishi R, Mine N, Kondo Y, Kawabe T, Omata M: Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk location. Hepatology 2006; 43: 1101-1108.
23. Wong SN, Lin CC, Lin CJ, Chen WT, Cua IHN, Lin SM: Combined radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locations. Am J Roentgenol 2008; 190:W187-W195.
24. Mulier S, Mulier P, Ni Y, Dupas MB, Marchal G, De Wever I, Michel L: Complications of radiofrequency coagulation of liver tumors. Br J Surg 2002; 89: 1206-1222.
25. Lu DS, Raman SS, Vodopich DJ, Wang M, Sayre J, Lassman C: Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the 'heat-sink' effect. Am J Roentgenol 2002; 178: 47-51.
26. Zhang YJ, Liang HH, Chen MS, Guo RP, Li JQ, Zheng Y, Zhang YQ, Lau WY: Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial. Radiology 2007; 244: 599-607.
27. Goldberg SN, Kruskal JB, Oliver BS, Clouse ME, Gazelle MS: Percutaneous tumor ablation: increasing coagulation by combining radiofrequency ablation and ethanol instillation in a rat breast tumor model. Radiology 2000; 217: 827-831.
28. Fernandes ML, Lin CC, Lin CJ, Chen WT, Lin SM: Risk of tumor progression in earlystage hepatocellular carcinoma after radiofrequency ablation. Br J Surg 2009; 96: 756-762.
29. Mazzaferro V, Battiston C, Perrone S, Pulvirenti A, Regalia E, Romito R, et al: Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg 2004; 240: 900-909.
30. Lu DS, Yu NC, Raman SS, Lassman C, Tong MJ, Britten C, et al: Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology 2005; 41: 1130-1137.
31. Brillet PY, Paradis V, Brancatelli G, Rangheard AS, Consigny Y, Plessier A, et al: Percutaneous radiofrequency ablation for hepatocellular carcinoma before liver transplantation: a prospective study with histopathologic comparison. Am J Roentgenol 2006; 186(suppl 5):S296-S305.
32. Kondo Y, Yoshida H, Shiina S, Tateishi R, Teratani T, Omata M: Artificial ascites technique for percutaneous radiofrequency ablation of liver cancer adjacent to the gastrointestinal tract. Br J Surg 2006; 93: 1277-1282.
33. Kondo Y, Yoshida H, Tateishi R, Shiina S, Kawabe T, Omata M: Percutaneous radiofrequency ablation of liver cancer in the hepatic dome using the intrapleural fluid infusion technique. Br J Surg 2008; 95: 996-1004.
34. Limquiaco JL, Fernandes M, Lin CJ, Lin CC, Chen WT, Lin SM: Radiofrequency ablation for hepatocellular carcinoma: artificial ascites for tumors in high-risk locations improves survival. Hepatol Int 2009; 3: 68.